rs830995
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004525.3(LRP2):c.1976-59T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.703 in 1,600,436 control chromosomes in the GnomAD database, including 398,817 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.69 ( 36325 hom., cov: 31)
Exomes 𝑓: 0.70 ( 362492 hom. )
Consequence
LRP2
NM_004525.3 intron
NM_004525.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.16
Publications
12 publications found
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
- Donnai-Barrow syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- Stickler syndromeInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- intellectual disabilityInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 2-169273126-A-G is Benign according to our data. Variant chr2-169273126-A-G is described in ClinVar as Benign. ClinVar VariationId is 1232462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.886 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LRP2 | NM_004525.3 | c.1976-59T>C | intron_variant | Intron 14 of 78 | ENST00000649046.1 | NP_004516.2 | ||
| LRP2 | XM_011511183.4 | c.1976-59T>C | intron_variant | Intron 14 of 77 | XP_011509485.1 | |||
| LRP2 | XM_047444340.1 | c.1052-59T>C | intron_variant | Intron 14 of 78 | XP_047300296.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LRP2 | ENST00000649046.1 | c.1976-59T>C | intron_variant | Intron 14 of 78 | NM_004525.3 | ENSP00000496870.1 | ||||
| LRP2 | ENST00000443831.1 | c.1769-59T>C | intron_variant | Intron 13 of 22 | 2 | ENSP00000409813.1 | ||||
| LRP2 | ENST00000493501.1 | n.319-59T>C | intron_variant | Intron 1 of 2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.688 AC: 104494AN: 151946Hom.: 36312 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
104494
AN:
151946
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.704 AC: 1020264AN: 1448372Hom.: 362492 AF XY: 0.701 AC XY: 505855AN XY: 721500 show subpopulations
GnomAD4 exome
AF:
AC:
1020264
AN:
1448372
Hom.:
AF XY:
AC XY:
505855
AN XY:
721500
show subpopulations
African (AFR)
AF:
AC:
21506
AN:
33196
American (AMR)
AF:
AC:
23461
AN:
44534
Ashkenazi Jewish (ASJ)
AF:
AC:
19879
AN:
25980
East Asian (EAS)
AF:
AC:
34592
AN:
39604
South Asian (SAS)
AF:
AC:
48021
AN:
85940
European-Finnish (FIN)
AF:
AC:
38773
AN:
52284
Middle Eastern (MID)
AF:
AC:
4288
AN:
5728
European-Non Finnish (NFE)
AF:
AC:
787315
AN:
1101206
Other (OTH)
AF:
AC:
42429
AN:
59900
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
16044
32088
48133
64177
80221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19606
39212
58818
78424
98030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.688 AC: 104549AN: 152064Hom.: 36325 Cov.: 31 AF XY: 0.684 AC XY: 50876AN XY: 74338 show subpopulations
GnomAD4 genome
AF:
AC:
104549
AN:
152064
Hom.:
Cov.:
31
AF XY:
AC XY:
50876
AN XY:
74338
show subpopulations
African (AFR)
AF:
AC:
26683
AN:
41486
American (AMR)
AF:
AC:
9028
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
2636
AN:
3470
East Asian (EAS)
AF:
AC:
4676
AN:
5152
South Asian (SAS)
AF:
AC:
2695
AN:
4822
European-Finnish (FIN)
AF:
AC:
7826
AN:
10586
Middle Eastern (MID)
AF:
AC:
211
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48602
AN:
67958
Other (OTH)
AF:
AC:
1518
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1667
3334
5000
6667
8334
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2425
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.